Skip to main content

Table 1 Baseline characteristics

From: Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart)

N HC 215 UC 215 P-value
Age, year 61.3 (11.3) 59.9 (11.1) 0.212
Male,% 75.8% 73.5% 0.579
Smoking status
  • Never smoked 25.1% 30.2% 0.398
  • Previous smoker 43.7% 38.1%
  • Current smoker 31.1% 31.6%
Doctor visits in last six months 4.55 (4.18) 4.79 (4.24) 0.588
Number of times admitted to hospital in last six months 1.99 (0.95) 1.97 (0.95) 0.840